Comparison of iLTS and LMA Fastrach in a Simulated Airway.

April 13, 2019 updated by: Marc Kriege, MD, Johannes Gutenberg University Mainz

Comparison of the Novel iLTS and Fastrach Intubation Laryngeal Mask for Time to Ventilation in a Simulated Airway.

Comparison of time to ventilation based on the chest rising of the Airway Simulator between the iLTS-D and LMA Fastrach

Study Overview

Detailed Description

Prior to the study every participant obtained a standardized instruction of each device. In the proposed clinical trial the primary study objective will be to determine whether there is a difference in time to ventilation via endotracheal tube (seconds) for the novel iLTS-D compared to the LMA Fastrach. Time to Ventilation will be defined from when the tip of the extraglottic airway device passed the incisors to the point until confirmation the first chest rise of the high fidelity simulator (Laerdal SimMan). Additionally, two time points before final tracheal placement will evaluated: time to place the EGA and time to ventilate with the EGA after introducing the device into the oral cavity.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germany, D55131
        • Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Medical students
  • Present written informed consent of the research participant

Exclusion Criteria:

• inability to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Time to ventilation with the iLTS
Measuring the time to ventilation (ET) based of insert the iLTS until the chest rise of the simulator in seconds
Time to ventilation (ET) based of insert the iLTS until the chest rise of the simulator in seconds
Time to ventilation (ET) based of insert the Fastrach until the chest rise of the simulator in seconds
Experimental: Time to ventilation with the Fastrach
Measuring time to ventilation (ET) based of insert the Fastrach until the chest rise of the simulator in seconds
Time to ventilation (ET) based of insert the iLTS until the chest rise of the simulator in seconds
Time to ventilation (ET) based of insert the Fastrach until the chest rise of the simulator in seconds

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to ventilation via endotracheal tube
Time Frame: 0 to 300 seconds
time to ventilation will defined from when the Endotracheal tube insert into the extraglottic airway device until the first chest rise
0 to 300 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to ventilation via extraglottic airway device
Time Frame: 0 to 300 seconds
time to ventilation will defined from when the device tip passed the incisors to the point until the first chest rise
0 to 300 seconds
Intubation attempts
Time Frame: 0 to 300 seconds
Numbers of successful intubation attempts (1-5 attempts)
0 to 300 seconds
Ease of Insertion
Time Frame: 0 to 420 seconds
Subjective Grading of the insertion process (Lickert Scale from 1 very easy to 5 very difficult)
0 to 420 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Thomas Ott, MD, Johannes GU, Mainz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

September 28, 2018

Study Completion (Actual)

December 28, 2018

Study Registration Dates

First Submitted

May 20, 2018

First Submitted That Met QC Criteria

May 20, 2018

First Posted (Actual)

May 31, 2018

Study Record Updates

Last Update Posted (Actual)

April 16, 2019

Last Update Submitted That Met QC Criteria

April 13, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • JohannesGUN

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilation Therapy; Complications

Clinical Trials on Time to ventilation with the iLTS

3
Subscribe